newsfilter
← Latest News
Business Wire·

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Focused Execution Drove 18% Operational Revenue Growth of Launched and Acquired Products(1) Advancing Robust Late-Stage Pipeline, with Several Key Pivotal Readouts Expected Over Next 12 Months Announces